吉格纳公司实行改革,以降低药物成本,提高顾客的透明度。 Cigna introduces reforms to lower drug costs and enhance transparency for customers.

Cigna是一家主要的保健提供者,它正在实施改革,使处方药价格对顾客更加可预测和透明。 Cigna, a major healthcare provider, is implementing reforms to make prescription drug prices more predictable and transparent for customers. 这些变化包括药物成本降低、个人化成本摘要和雇主报告改进。 These changes include lower drug costs, personalized cost summaries, and enhanced reports for employers. 拥有Express Scripts的Cigna旨在解决对高药价的批评,特别是GLP-1药品的批评,并提高药品成本的透明度和可负担性. Cigna, which owns Express Scripts, aims to address criticisms about high drug prices, especially for GLP-1 drugs, and improve transparency and affordability in medication costs.